Usama Gergis
Experienced in Primary Immunodeficiency (PID)

Dr. Usama Gergis

Transplant Surgery | Oncology
Jefferson Health
Jefferson Cancer - Honickman Center
1101 Chestnut Street, Floor 14, 
Philadelphia, PA 
Accepting New Patients
29 Years of Experience
Experienced in Primary Immunodeficiency (PID)
Jefferson Health
Jefferson Cancer - Honickman Center
1101 Chestnut Street, Floor 14, 
Philadelphia, PA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Usama Gergis is an Oncologist and a Transplant Surgeon in Philadelphia, Pennsylvania. Dr. Gergis has been practicing medicine for over 29 years and is rated as an Experienced provider by MediFind in the treatment of Primary Immunodeficiency (PID). His top areas of expertise are Graft Versus Host Disease (GvHD), Acute Myeloid Leukemia (AML), Multiple Myeloma, Bone Marrow Transplant, and Bone Graft. Dr. Gergis is currently accepting new patients.

His clinical research consists of co-authoring 147 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution
University Of Cairo Faculty Of Medicine
Residency
Brookdale Hospital Medical Center
Specialties
Transplant Surgery
Oncology
Licenses
Internal Medicine in NY
Board Certifications
Hematology
Fellowships
Brooklyn Hospital Center
Moffitt Cancer Center
Hospital Affiliations
Jefferson Abington Hospital
Thomas Jefferson University Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Geisinger
  • HMO
  • POS
  • PPO
Health Partners Plans
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
PA Health and Wellness
  • HMO
  • MANAGED MEDICAID PLAN
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
UPMC
  • EPO
  • PPO
View 5 Less Insurance Carriers -

Locations

Jefferson Cancer - Honickman Center
1101 Chestnut Street, Floor 14, Philadelphia, PA 19107
Call: 215-955-8874
Other Locations
Asplundh Cancer Pavilion
3941 Commerce Avenue, Willow Grove, PA 19090
Call: 215-481-4000

Additional Areas of Focus

Dr. Gergis has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Mesothelioma

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Phase 2, Open-label, Multicenter Study of the Safety and Efficacy of TAK-007 in Adult Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
A Phase 2, Open-label, Multicenter Study of the Safety and Efficacy of TAK-007 in Adult Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
Enrollment Status: Active_not_recruiting
Publish Date: August 12, 2025
Intervention Type: Drug, Biological
Study Drugs: TAK-007, Chemotherapy Agents
Study Phase: Phase 2
A Phase 1 Study of PBCAR19B in Participants With CD19-expressing Malignancies
A Phase 1 Study of PBCAR19B in Participants With CD19-expressing Malignancies
Enrollment Status: Completed
Publish Date: July 26, 2024
Intervention Type: Genetic
Study Phase: Phase 1
Parallel Phase II Trial of IPA Targeted Adoptive Immunotherapy vs Adult Haplo-identical Cell Infusion During Induction of High Risk Leukemia
Parallel Phase II Trial of IPA Targeted Adoptive Immunotherapy vs Adult Haplo-identical Cell Infusion During Induction of High Risk Leukemia
Enrollment Status: Terminated
Publish Date: February 13, 2024
Intervention Type: Biological
Study Drugs: Haplo-identical cells, Umbilical cord blood unit
Study Phase: Phase 2
A Pilot Study of a Novel Sequential Treatment Utilizing CPX-351 as Salvage Chemotherapy Followed by Allogeneic Stem-Cell Transplantation (SCT) Utilizing a Haplo-cord Graft for Patients With Relapsed or Refractory Leukemia or Myelodysplastic Syndrome
A Pilot Study of a Novel Sequential Treatment Utilizing CPX-351 as Salvage Chemotherapy Followed by Allogeneic Stem-Cell Transplantation (SCT) Utilizing a Haplo-cord Graft for Patients With Relapsed or Refractory Leukemia or Myelodysplastic Syndrome
Enrollment Status: Completed
Publish Date: December 21, 2022
Intervention Type: Drug, Biological
Study Drugs: CPX-351, Fludarabine, Melphalan, Rabbit Anti-Human T-Lymphocyte Globulin, Haplo-Cord Stem Cell Transplantation
Study Phase: Phase 1
Epigenetic Priming With 5-Azacytidine Prior to in Vivo T-cell Depleted Allogeneic Stem Cell Transplantation for Patients With High Risk Myeloid Malignancies in Morphologic Remission
Epigenetic Priming With 5-Azacytidine Prior to in Vivo T-cell Depleted Allogeneic Stem Cell Transplantation for Patients With High Risk Myeloid Malignancies in Morphologic Remission
Enrollment Status: Completed
Publish Date: September 22, 2021
Intervention Type: Radiation, Drug
Study Drugs: 5-Azacytidine, Fludarabine, Melphalan, Alemtuzumab
Study Phase: Phase 2
View 4 Less Clinical Trials

147 Total Publications

Correction: Non-cryopreserved autologous peripheral blood stem cell transplantation for multiple myeloma and lymphoma in countries with limited resources: practice considerations from the Worldwide Network for Blood and Marrow Transplantation.
Correction: Non-cryopreserved autologous peripheral blood stem cell transplantation for multiple myeloma and lymphoma in countries with limited resources: practice considerations from the Worldwide Network for Blood and Marrow Transplantation.
Journal: Bone marrow transplantation
Published: June 30, 2025
View All 147 Publications
Similar Doctors
Advanced in Primary Immunodeficiency (PID)
Dr. Lee Hartner
Hematology | Oncology
Advanced in Primary Immunodeficiency (PID)
Dr. Lee Hartner
Hematology | Oncology

Abramson Cancer Center Radnor

145 King Of Prussia Road, Floor 2, Suite 200 North, 
Radnor, PA 
 (12.2 miles away)
800-789-7366
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Lee Hartner is a Hematologist and an Oncologist in Radnor, Pennsylvania. Dr. Hartner is rated as a Distinguished provider by MediFind in the treatment of Primary Immunodeficiency (PID). His top areas of expertise are Adult Soft Tissue Sarcoma, Retroperitoneal Liposarcoma, Liposarcoma, Gastrostomy, and Endoscopy. Dr. Hartner is currently accepting new patients.

Experienced in Primary Immunodeficiency (PID)
Dr. Sameer K. Gupta
Hematology Oncology | Hematology | Oncology
Experienced in Primary Immunodeficiency (PID)
Dr. Sameer K. Gupta
Hematology Oncology | Hematology | Oncology

Bryn Mawr Medical Specialists Association

825 Old Lancaster Rd, Suite 320, 
Bryn Mawr, PA 
 (10.0 miles away)
Languages Spoken:
English
See accepted insurances

Sameer Gupta is a Hematologist Oncology specialist and a Hematologist in Bryn Mawr, Pennsylvania. Dr. Gupta is rated as a Distinguished provider by MediFind in the treatment of Primary Immunodeficiency (PID). His top areas of expertise are Non-Hodgkin Lymphoma, Omenn Syndrome, Paget Disease of the Breast, Gallbladder Removal, and Penectomy.

Experienced in Primary Immunodeficiency (PID)
Dr. Daniel J. Lebovic
Hematology Oncology | Hematology | Oncology
Experienced in Primary Immunodeficiency (PID)
Dr. Daniel J. Lebovic
Hematology Oncology | Hematology | Oncology

Alliance Cancer Specialists P.C.

1203 Langhorne Newtown Rd, Suite 135, 
Langhorne, PA 
 (21.3 miles away)
215-750-5050
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Daniel Lebovic is a Hematologist Oncology specialist and a Hematologist in Langhorne, Pennsylvania. Dr. Lebovic is rated as a Distinguished provider by MediFind in the treatment of Primary Immunodeficiency (PID). His top areas of expertise are Colorectal Cancer, Childhood Iron Deficiency Anemia, Familial Colorectal Cancer, Bone Marrow Aspiration, and Gastrostomy.

VIEW MORE PRIMARY IMMUNODEFICIENCY (PID) DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Gergis's expertise for a condition
ConditionClose
  • Elite
  • Graft Versus Host Disease (GvHD)
    Dr. Gergis is
    Elite
    . Learn about Graft Versus Host Disease (GvHD).
    See more Graft Versus Host Disease (GvHD) experts
  • Distinguished
  • Acute Myeloid Leukemia (AML)
    Dr. Gergis is
    Distinguished
    . Learn about Acute Myeloid Leukemia (AML).
    See more Acute Myeloid Leukemia (AML) experts
  • Bone Marrow Transplant
    Dr. Gergis is
    Distinguished
    . Learn about Bone Marrow Transplant.
    See more Bone Marrow Transplant experts
  • Multiple Myeloma
    Dr. Gergis is
    Distinguished
    . Learn about Multiple Myeloma.
    See more Multiple Myeloma experts
  • Non-Hodgkin Lymphoma
    Dr. Gergis is
    Distinguished
    . Learn about Non-Hodgkin Lymphoma.
    See more Non-Hodgkin Lymphoma experts
  • Relapsed Refractory Multiple Myeloma (RRMM)
    Dr. Gergis is
    Distinguished
    . Learn about Relapsed Refractory Multiple Myeloma (RRMM).
    See more Relapsed Refractory Multiple Myeloma (RRMM) experts
  • Advanced
  • Acute Lymphoblastic Leukemia (ALL)
    Dr. Gergis is
    Advanced
    . Learn about Acute Lymphoblastic Leukemia (ALL).
    See more Acute Lymphoblastic Leukemia (ALL) experts
  • Acute Myeloblastic Leukemia with Maturation
    Dr. Gergis is
    Advanced
    . Learn about Acute Myeloblastic Leukemia with Maturation.
    See more Acute Myeloblastic Leukemia with Maturation experts
  • Acute Myeloblastic Leukemia without Maturation
    Dr. Gergis is
    Advanced
    . Learn about Acute Myeloblastic Leukemia without Maturation.
    See more Acute Myeloblastic Leukemia without Maturation experts
  • B-Cell Lymphoma
    Dr. Gergis is
    Advanced
    . Learn about B-Cell Lymphoma.
    See more B-Cell Lymphoma experts
  • Childhood Acute Myeloid Leukemia
    Dr. Gergis is
    Advanced
    . Learn about Childhood Acute Myeloid Leukemia.
    See more Childhood Acute Myeloid Leukemia experts
  • Chronic Graft Versus Host Disease (cGvHD)
    Dr. Gergis is
    Advanced
    . Learn about Chronic Graft Versus Host Disease (cGvHD).
    See more Chronic Graft Versus Host Disease (cGvHD) experts
View All 11 Advanced Conditions
  • Experienced
  • Acute Myelomonocytic Leukemia
    Dr. Gergis is
    Experienced
    . Learn about Acute Myelomonocytic Leukemia.
    See more Acute Myelomonocytic Leukemia experts
  • Adult Immune Thrombocytopenia
    Dr. Gergis is
    Experienced
    . Learn about Adult Immune Thrombocytopenia.
    See more Adult Immune Thrombocytopenia experts
  • Agranulocytosis
    Dr. Gergis is
    Experienced
    . Learn about Agranulocytosis.
    See more Agranulocytosis experts
  • Anemia
    Dr. Gergis is
    Experienced
    . Learn about Anemia.
    See more Anemia experts
  • Aplastic Anemia
    Dr. Gergis is
    Experienced
    . Learn about Aplastic Anemia.
    See more Aplastic Anemia experts
  • Atypical Hemolytic Uremic Syndrome (aHUS)
    Dr. Gergis is
    Experienced
    . Learn about Atypical Hemolytic Uremic Syndrome (aHUS).
    See more Atypical Hemolytic Uremic Syndrome (aHUS) experts
View All 45 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile
For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2026 All Rights Reserved

    Request an Appointment

    If you are experiencing a medical emergency, call 9-1-1.

    MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

    Patient Details

    This information is for the patient who will be seen at the appointment.

      Close

      Returning patient? Use your address on file with the provider.

      Insurance Details

      Please provide information of the primary insurance holder as the practice may require this information to schedule.

      Insurance Provider *
      Insurance ProviderClose

      Appointments Details

      Let’s get more information about your appointment.

              0 / 1000
              0 / 1000
              By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.